Drugs to treat diseases from cancer to AIDS could soon rely on short strands of RNA for their effects. But scientists must first work out how to navigate these fragments around the body. Nathan Blow reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Elbashir, S. M. et al. Nature 411, 494–498 (2001).
Soutschek, J. et al. Nature 432, 173–178 (2004).
Zimmermann, T. S. et al. Nature 441, 111–114 (2006).
Yang L., Bailey, L., Baltimore, D. & Wang, P. Proc. Natl Acad. Sci. USA 103, 11479–11484 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blow, N. Delivering the future. Nature 450, 1119–1120 (2007). https://doi.org/10.1038/4501117a
Published:
Issue date:
DOI: https://doi.org/10.1038/4501117a
This article is cited by
-
Personalized Cancer Approach: Using RNA Interference Technology
World Journal of Surgery (2011)
-
Octa-guanidine Morpholino Restores Dystrophin Expression in Cardiac and Skeletal Muscles and Ameliorates Pathology in Dystrophic mdx Mice
Molecular Therapy (2009)
-
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Nature Biotechnology (2009)
